Kindred Biosciences, Inc. (KIN) Stock Analysis
DELISTED 2021
What happened to Kindred Biosciences, Inc. (KIN) stock?
Kindred Biosciences, Inc. (KIN) no longer trades on public markets. It was delisted in August 2021. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- August 2021
- Last recorded price (historical):
- $9.25 (last quote on record before the August 2021 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Kindred Biosciences, Inc. (KIN). Kindred Biosciences, Inc. is a biopharmaceutical company focused on developing novel biologics for companion animals, addressing various therapeutic needs in pet health.
Last analyzed: Jun 14, 2026Kindred Biosciences, Inc. (KIN) Healthcare & Pipeline Overview
More about this archive record
Can I still buy KIN shares?
No. KIN stopped trading on public markets in August 2021, so the shares are not available through a broker. Anything you see quoted for KIN elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before KIN stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Kindred Biosciences, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.